Evidence map›Paper›PMID 28166722›Full record

ArticleBMC genomics2017

Integration of VDR genome wide binding and GWAS genetic variation data reveals co-occurrence of VDR and NF-κB binding that is linked to immune phenotypes.

Prashant K Singh, Patrick R van den Berg, Mark D Long, Angie Vreugdenhil, Laurie Grieshober, Heather M Ochs-Balcom, Jianmin Wang, Sylvie Delcambre, Sami Heikkinen, Carsten Carlberg and 2 more

Open access · goldAbstract read
In one paragraph

Article in BMC genomics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 42 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Vitamin D Receptor Regulates the Expression of the Grainyhead-Like 1 Gene.International journal of molecular sciences · 2024
    Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Vitamin D Receptor Signaling and Cancer.Endocrinology and metabolism clinics of North America · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 4 countries.

Prashant K SinghDepartment of Pharmacology & Therapeutics, Roswell Park Cancer Institute, Buffalo, NY, 14263, USA.
Patrick R van den BergLeiden institute of Physics, Leiden University, 2300 RA, Leiden, Netherlands.
Mark D LongDepartment of Pharmacology & Therapeutics, Roswell Park Cancer Institute, Buffalo, NY, 14263, USA.
Angie VreugdenhilDepartment of Pharmacology & Therapeutics, Roswell Park Cancer Institute, Buffalo, NY, 14263, USA.
Laurie GrieshoberDepartment of Epidemiology and Environmental Health, School of Public Health and Health Professions, University at Buffalo, Buffalo, NY, 14214, USA.
Heather M Ochs-BalcomDepartment of Epidemiology and Environmental Health, School of Public Health and Health Professions, University at Buffalo, Buffalo, NY, 14214, USA.
Jianmin WangDepartment of Biostatistics and Bioinformatics, Roswell Park Cancer Institute, Buffalo, NY, 14263, USA.
Sylvie DelcambreLuxembourg Centre for Systems Biomedicine, 6 Avenue du Swing, 4367, Belvaux, Luxembourg.
Sami HeikkinenSchool of Medicine, Institute of Biomedicine, University of Eastern Finland, Kuopio, 70211, Finland.
Carsten CarlbergSchool of Medicine, Institute of Biomedicine, University of Eastern Finland, Kuopio, 70211, Finland.
Moray J CampbellDivision of Pharmaceutics and Pharmaceutical Chemistry, College of Pharmacy, 536 Parks Hall, The Ohio State University, Columbus, OH, 43210, USA. Campbell.1933@osu.edu.
Lara E Sucheston-CampbellDivision of Pharmacy Practice and Science, College of Pharmacy, 604 Riffe Building, The Ohio State University, Columbus, OH, 43210, USA. sucheston-campbell.1@osu.edu.
Roswell Park Comprehensive Cancer Center · USThe Ohio State University · USUniversity at Buffalo, State University of New York · USUniversity of Eastern Finland · FILeiden University · NLUniversity of Luxembourg · LU

Funding

Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Jennifer A. Woyach · 1985 to 2026
$132.3M
RPCI-UPCI Ovarian Cancer SPOREP50CA159981 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI MOYSICH, KIRSTEN B., ODUNSI, KUNLE · 2013 to 2025
$19.6M
Interdisciplinary Training in Cancer Epidemiology at UBR25CA113951 · NCI · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI FREUDENHEIM, JO L., MOYSICH, KIRSTEN B. · 2007 to 2016
$2.5M
DRUG DEVELOPMENT AND CANCER TREATMENTST32CA009072 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI JOHNSON, CANDACE S · 1985 to 2014
$2.3M
Estrogen Receptor 1 Gene, Adiposity, and Breast CancerK07CA136969 · NCI · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI OCHS-BALCOM, HEATHER M · 2009 to 2013
$810k
NCI NIH HHS K07 CA136969NCI NIH HHS P30 CA016058NCI NIH HHS P50 CA159981NCI NIH HHS R25 CA113951NCI NIH HHS T32 CA009072
6 · The paper itself

Abstract

backgroundThe nuclear hormone receptor superfamily acts as a genomic sensor of diverse signals. Their actions are often intertwined with other transcription factors. Nuclear hormone receptors are targets for many therapeutic drugs, and include the vitamin D receptor (VDR). VDR signaling is pleotropic, being implicated in calcaemic function, antibacterial actions, growth control, immunomodulation and anti-cancer actions. Specifically, we hypothesized that the biologically significant relationships between the VDR transcriptome and phenotype-associated biology could be discovered by integrating the known VDR transcription factor binding sites and all published trait- and disease-associated SNPs. By integrating VDR genome-wide binding data (ChIP-seq) with the National Human Genome Research Institute (NHGRI) GWAS catalog of SNPs we would see where and which target gene interactions and pathways are impacted by inherited genetic variation in VDR binding sites, indicating which of VDR's multiple functions are most biologically significant.

resultsTo examine how genetic variation impacts VDR function we overlapped 23,409 VDR genomic binding peaks from six VDR ChIP-seq datasets with 191,482 SNPs, derived from GWAS-significant SNPs (Lead SNPs) and their correlated variants (r

conclusionsThese analyses showed that VDR peaks are enriched for SNPs associated with immune phenotypes suggesting that VDR immunomodulatory functions are amongst its most important actions. The enrichment of genetic variation in non-DR3 motifs suggests a significant role for the VDR to bind in multimeric complexes containing other transcription factors that are the primary DNA binding component. Our work provides a framework for the combination of ChIP-seq and GWAS findings to provide insight into the underlying phenotype-associated biology of a given transcription factor.

Indexed as

Genome-Wide Association StudyPhenotypePolymorphism, Single NucleotideCell LineGenomicsHumansImmunityLinkage DisequilibriumNF-kappa BProtein BindingReceptors, CalcitriolTranscription FactorsNF-kappa BReceptors, CalcitriolTranscription FactorsVDR protein, humanChIP-seqCistromeDR3 motifGWASImmune functionLinkage disequilibriumNF-κBNuclear receptor superfamilySNPVDR

Identifiers

PMID28166722
PMCPMC5294817
OpenAlexW2587515044

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.